A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 4, 2014, Pages

  Romeo, Martin J ^a   Agrawal, Rachana ^a   Pomés, Anna ^b   Woodfolk, Judith A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b INDOOR Biotechnologies Inc   (United States)

Author keywords

allergy; asthma treatment; cytokines; IL 13; IL 4; receptors; Thymic stromal lymphopoietin

Indexed keywords

CYTOKINE RECEPTOR; DOUBLE STRANDED RNA; DUPILUMAB; FIBRONECTIN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; JANUS KINASE; LEBRIKIZUMAB; MESSENGER RNA; MESSENGER RNA PRECURSOR; NEUTROPHIL COLLAGENASE; PITRAKINRA; THYMIC STROMAL LYMPHOPOIETIN; THYMIC STROMAL LYMPHOPOIETIN RECEPTOR; UNCLASSIFIED DRUG; CYTOKINE;

3' UNTRANSLATED REGION; ALLERGIC ASTHMA; ALLERGIC DISEASE; ALTERNATIVE RNA SPLICING; ANTIBODY PRODUCTION; ASTHMA; BINDING AFFINITY; CELL DIFFERENTIATION; COMPLEX FORMATION; CYTOKINE RELEASE; DIMERIZATION; DISULFIDE BOND; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIGAND BINDING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL; UPREGULATION; X LINKED SEVERE COMBINED IMMUNODEFICIENCY; ALLERGY; ANIMAL; ASTHMA TREATMENT; CHEMISTRY; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTORS; SIGNAL TRANSDUCTION; T(H)2;

ALLERGY; ASTHMA TREATMENT; CYTOKINES; IL-13; IL-4; RECEPTORS; T(H)2; THYMIC STROMAL LYMPHOPOIETIN;

ANIMALS; CYTOKINES; HUMANS; HYPERSENSITIVITY; PROTEIN BINDING; PROTEIN INTERACTION MAPS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84897412926     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.08.006     Document Type: Article

References (97)

1. T. Ito, Y.H. Wang, O. Duramad, T. Hori, G.J. Delespesse, and N. Watanabe et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand J Exp Med 202 2005 1213 1223
2. S.F. Ziegler Thymic stromal lymphopoietin and allergic disease J Allergy Clin Immunol 130 2012 845 852
3. X. Wang, M. Rickert, and K.C. Garcia Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors Science 310 2005 1159 1163
4. S.L. LaPorte, Z.S. Juo, J. Vaclavikova, L.A. Colf, X. Qi, and N.M. Heller et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system Cell 132 2008 259 272
5. S.T. Walsh Structural insights into the common gamma-chain family of cytokines and receptors from the interleukin-7 pathway Immunol Rev 250 2012 303 316
6. M. Rickert, X. Wang, M.J. Boulanger, N. Goriatcheva, and K.C. Garcia The structure of interleukin-2 complexed with its alpha receptor Science 308 2005 1477 1480
7. X. Wang, P. Lupardus, S.L. Laporte, and K.C. Garcia Structural biology of shared cytokine receptors Annu Rev Immunol 27 2009 29 60
8. R. Dagil, M.J. Knudsen, J.G. Olsen, C. O'Shea, M. Franzmann, and V. Goffin et al. The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor Structure 20 2012 270 282
9. A.R. Cole, N.E. Hall, H.R. Treutlein, J.S. Eddes, G.E. Reid, and R.L. Moritz et al. Disulfide bond structure and N-glycosylation sites of the extracellular domain of the human interleukin-6 receptor J Biol Chem 274 1999 7207 7215
10. J. Zhong, and A. Pandey Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Ralpha and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation BMC Immunol 11 2010 5
11. K. Arima, N. Watanabe, S. Hanabuchi, M. Chang, S.C. Sun, and Y.J. Liu Distinct signal codes generate dendritic cell functional plasticity Sci Signal 3 2010 ra4
12. M. Wills-Karp, and F.D. Finkelman Untangling the complex web of IL-4- and IL-13-mediated signaling pathways Sci Signal 1 2008 pe55
13. A. Bhattacharjee, M. Shukla, V.P. Yakubenko, A. Mulya, S. Kundu, and M.K. Cathcart IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages Free Radic Biol Med 54 2013 1 16
14. C.A. McElroy, P.J. Holland, P. Zhao, J.M. Lim, L. Wells, and E. Eisenstein et al. Structural reorganization of the interleukin-7 signaling complex Proc Natl Acad Sci U S A 109 2012 2503 2508
15. W. Kammer, A. Lischke, R. Moriggl, B. Groner, A. Ziemiecki, and C.B. Gurniak et al. Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling J Biol Chem 271 1996 23634 23637
16. A.H. Pillet, O. Juffroy, V. Mazard-Pasquier, J.L. Moreau, F. Gesbert, and P. Chastagner et al. Human IL-Rbeta chains form IL-2 binding homodimers Eur Cytokine Netw 19 2008 49 59
17. Y. Malka, T. Hornakova, Y. Royer, L. Knoops, J.C. Renauld, and S.N. Constantinescu et al. Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain J Biol Chem 283 2008 33569 33577
18. T. Rose, A.H. Pillet, V. Lavergne, B. Tamarit, P. Lenormand, and J.C. Rousselle et al. Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response J Biol Chem 285 2010 14898 14908
19. D.J. Hilton, J.G. Zhang, D. Metcalf, W.S. Alexander, N.A. Nicola, and T.A. Willson Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor Proc Natl Acad Sci U S A 93 1996 497 501
20. T. Ito, S. Suzuki, S. Kanaji, H. Shiraishi, S. Ohta, and K. Arima et al. Distinct structural requirements for interleukin-4 (IL-4) and IL-13 binding to the shared IL-13 receptor facilitate cellular tuning of cytokine responsiveness J Biol Chem 284 2009 24289 24296
21. I.S. Junttila, K. Mizukami, H. Dickensheets, M. Meier-Schellersheim, H. Yamane, and R.P. Donnelly et al. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity J Exp Med 205 2008 2595 2608
22. F.P. Heinzel, M.D. Sadick, B.J. Holaday, R.L. Coffman, and R.M. Locksley Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets J Exp Med 169 1989 59 72
23. D.A. Lebman, and R.L. Coffman Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures J Exp Med 168 1988 853 862
24. N.M. Heller, W.M. Gwinn, R.P. Donnelly, S.L. Constant, and A.D. Keegan IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro PLoS One 7 2012 e39673
25. M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, and C.L. Karp et al. Interleukin-13: central mediator of allergic asthma Science 282 1998 2258 2261
26. G. Grunig, M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, and D.M. Rennick et al. Requirement for IL-13 independently of IL-4 in experimental asthma Science 282 1998 2261 2263
27. I.S. Junttila, R.J. Creusot, I. Moraga, D.L. Bates, M.T. Wong, and M.N. Alonso et al. Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines Nat Chem Biol 8 2012 990 998
28. M. Noguchi, Y. Nakamura, S.M. Russell, S.F. Ziegler, M. Tsang, and X. Cao et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor Science 262 1993 1877 1880
29. A. Pandey, K. Ozaki, H. Baumann, S.D. Levin, A. Puel, and A.G. Farr et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin Nat Immunol 1 2000 59 64
30. R.J. Armitage, S.F. Ziegler, M.P. Beckmann, R.L. Idzerda, L.S. Park, and W.C. Fanslow Expression of receptors for interleukin 4 and interleukin 7 on human T cells Adv Exp Med Biol 292 1991 121 130
31. T. Sudo, S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, and H. Yoshida et al. Expression and function of the interleukin 7 receptor in murine lymphocytes Proc Natl Acad Sci U S A 90 1993 9125 9129
32. C.K. Wong, S. Hu, P.F. Cheung, and C.W. Lam Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation Am J Respir Cell Mol Biol 43 2010 305 315
33. A.J. Reefer, K.E. Hulse, J.A. Lannigan, M.D. Solga, P.W. Wright, and L.A. Kelly et al. Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a "proallergic" milieu J Allergy Clin Immunol 126 2010 1049 1058 e1-10
34. I. Rochman, N. Watanabe, K. Arima, Y.J. Liu, and W.J. Leonard Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells J Immunol 178 2007 6720 6724
35. L.S. Park, U. Martin, K. Garka, B. Gliniak, J.P. Di Santo, and W. Muller et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor J Exp Med 192 2000 659 670
36. R.J. Ray, C. Furlonger, D.E. Williams, and C.J. Paige Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro Eur J Immunol 26 1996 10 16
37. F.A. Scheeren, A.U. van Lent, M. Nagasawa, K. Weijer, H. Spits, and N. Legrand et al. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation Eur J Immunol 40 2010 955 965
38. W. Zhang, J. Wang, Q. Wang, G. Chen, J. Zhang, and T. Chen et al. Identification of a novel type I cytokine receptor CRL2 preferentially expressed by human dendritic cells and activated monocytes Biochem Biophys Res Commun 281 2001 878 883
39. A.B. Madhankumar, A. Mintz, and W. Debinski Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2 Neoplasia 6 2004 15 22
40. P.J. Lupardus, M.E. Birnbaum, and K.C. Garcia Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2 Structure 18 2010 332 342
41. I. Evsyukova, S.S. Bradrick, S.G. Gregory, and M.A. Garcia-Blanco Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6 RNA 19 2013 103 115
42. K. Prikk, P. Maisi, E. Pirila, M.A. Reintam, T. Salo, and T. Sorsa et al. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma Lab Invest 82 2002 1535 1545
43. J.I. Harper, H. Godwin, A. Green, L.E. Wilkes, N.J. Holden, and M. Moffatt et al. A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis Br J Dermatol 162 2010 397 403
44. S. Kruse, J. Forster, J. Kuehr, and K.A. Deichmann Characterization of the membrane-bound and a soluble form of human IL-4 receptor alpha produced by alternative splicing Int Immunol 11 1999 1965 1970
45. T. Jung, N. Schrader, M. Hellwig, K.H. Enssle, and C. Neumann Soluble human interleukin-4 receptor is produced by activated T cells under the control of metalloproteinases Int Arch Allergy Immunol 119 1999 23 30
46. T. Jung, K. Wagner, C. Neumann, and C.H. Heusser Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro Eur J Immunol 29 1999 864 871
47. L.Y. Zhu, P.P. Pan, W. Fang, J.Z. Shao, and L.X. Xiang Essential role of IL-4 and IL-4Ralpha interaction in adaptive immunity of zebrafish: insight into the origin of Th2-like regulatory mechanism in ancient vertebrates J Immunol 188 2012 5571 5584
48. W. Chen, U. Sivaprasad, Y. Tabata, A.M. Gibson, M.T. Stier, and F.D. Finkelman et al. IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice J Immunol 183 2009 7870 7876
49. Y. Tabata, W. Chen, M.R. Warrier, A.M. Gibson, M.O. Daines, and G.K. Hershey Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms J Immunol 177 2006 7905 7912
50. W. Chen, Y. Tabata, A.M. Gibson, M.O. Daines, M.R. Warrier, and M. Wills-Karp et al. Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo J Allergy Clin Immunol 122 2008 625 632
51. M.O. Daines, W. Chen, Y. Tabata, B.A. Walker, A.M. Gibson, and J.A. Masino et al. Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy J Allergy Clin Immunol 119 2007 375 383
52. M. O'Toole, H. Legault, R. Ramsey, T.A. Wynn, and M.T. Kasaian A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects Clin Exp Allergy 38 2008 594 601
53. K. Kawakami, J. Taguchi, T. Murata, and R.K. Puri The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway Blood 97 2001 2673 2679
54. K. Arima, R. Umeshita-Suyama, Y. Sakata, M. Akaiwa, X.Q. Mao, and T. Enomoto et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma J Allergy Clin Immunol 109 2002 980 987
55. W. Chen, U. Sivaprasad, A.M. Gibson, M.B. Ericksen, C.M. Cunningham, and S.A. Bass et al. IL-13 receptor α2 contributes to development of experimental allergic asthma J Allergy Clin Immunol 2013 [Epub ahead of print]
56. M. Yoshikawa, T. Nakajima, T. Tsukidate, K. Matsumoto, M. Iida, and N. Otori et al. TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts Biochem Biophys Res Commun 312 2003 1248 1255
57. B.J. Moynihan, B. Tolloczko, S. El Bassam, P. Ferraro, M.C. Michoud, and J.G. Martin et al. IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13 Respir Res 9 2008 84
58. M. David, D. Ford, J. Bertoglio, A.L. Maizel, and J. Pierre Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways Oncogene 20 2001 6660 6668
59. G. Campbell-Harding, H. Sawkins, N. Bedke, S.T. Holgate, D.E. Davies, and A.L. Andrews The innate antiviral response upregulates IL-13 receptor alpha2 in bronchial fibroblasts J Allergy Clin Immunol 131 2013 849 855
60. S. Fichtner-Feigl, W. Strober, K. Kawakami, R.K. Puri, and A. Kitani IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis Nat Med 12 2006 99 106
61. A.L. Andrews, T. Nasir, F. Bucchieri, J.W. Holloway, S.T. Holgate, and D.E. Davies IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts J Allergy Clin Immunol 118 2006 858 865
62. M. Harada, T. Hirota, A.I. Jodo, S. Doi, M. Kameda, and K. Fujita et al. Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells Am J Respir Cell Mol Biol 40 2009 368 374
63. Y. Xie, T. Takai, X. Chen, K. Okumura, and H. Ogawa Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes J Dermatol Sci 66 2012 233 237
64. D.R. Nagarkar, J.A. Poposki, B.K. Tan, M.R. Comeau, A.T. Peters, and K.E. Hulse et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis J Allergy Clin Immunol 2013 [Epub ahead of print]
65. W.J. Alms, S.P. Atamas, V.V. Yurovsky, and B. White Generation of a variant of human interleukin-4 by alternative splicing Mol Immunol 33 1996 361 370
66. I.G. Luzina, V. Lockatell, S. Lavania, E.M. Pickering, P.H. Kang, and Y.N. Bashkatova et al. Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma Cytokine 58 2012 20 26
67. Y. Arinobu, S.P. Atamas, T. Otsuka, H. Niiro, K. Yamaoka, and H. Mitsuyasu et al. Antagonistic effects of an alternative splice variant of human IL-4, IL-4delta2, on IL-4 activities in human monocytes and B cells Cell Immunol 191 1999 161 167
68. M.J. Romeo, R. Agrawal, A. Pomés, and J.A. Woodfolk Human basophils express novel TSLPR variants including a putative secreted form [abstract] J Allergy Clin Immunol 131 suppl 2013 AB102
69. J. Zhong, X. Liu, and A. Pandey Effects of transmembrane and juxtamembrane domains on proliferative ability of TSLP receptor Mol Immunol 47 2010 1207 1215
70. N. Carpino, W.E. Thierfelder, M.S. Chang, C. Saris, S.J. Turner, and S.F. Ziegler et al. Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development Mol Cell Biol 24 2004 2584 2592
71. T. Bartfai, P.T. Buckley, and J. Eberwine Drug targets: single-cell transcriptomics hastens unbiased discovery Trends Pharmacol Sci 33 2012 9 16
72. C. Reardon, M. Lechmann, A. Brustle, M.G. Gareau, N. Shuman, and D. Philpott et al. Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation Immunity 35 2011 223 235
73. I. Spadoni, I.D. Iliev, G. Rossi, and M. Rescigno Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis Mucosal Immunol 5 2012 184 193
74. B.C. Taylor, C. Zaph, A.E. Troy, Y. Du, K.J. Guild, and M.R. Comeau et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis J Exp Med 206 2009 655 667
75. M.M. Miazgowicz, M.S. Elliott, J.S. Debley, and S.F. Ziegler Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells J Inflamm Res 6 2013 53 61
76. H.C. Lee, M.B. Headley, Y.M. Loo, A. Berlin, M. Gale Jr., and J.S. Debley et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection J Allergy Clin Immunol 130 2012 1187 1196.e5
77. K.E. Hulse, A.J. Reefer, V.H. Engelhard, S.M. Satinover, J.T. Patrie, and M.D. Chapman et al. Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy J Allergy Clin Immunol 121 2008 756 762.e4
78. K.E. Hulse, A.J. Reefer, V.H. Engelhard, J.T. Patrie, S.F. Ziegler, and M.D. Chapman et al. Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatory pathway linked to thymic stromal lymphopoietin receptor J Allergy Clin Immunol 125 2010 247 256 e1-8
79. D. Kaur, F. Hollins, L. Woodman, W. Yang, P. Monk, and R. May et al. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression Allergy 61 2006 1047 1053
80. T.K. Hart, M.N. Blackburn, M. Brigham-Burke, K. Dede, N. Al-Mahdi, and P. Zia-Amirhosseini et al. Preclinical efficacy and safety of pascolizumab (9SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma Clin Exp Immunol 130 2002 93 100
81. G. Pelaia, A. Vatrella, and R. Maselli The potential of biologics for the treatment of asthma Nat Rev Drug Discov 11 2012 958 972
82. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, and J.R. Arron et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
83. G. Jia, R.W. Erickson, D.F. Choy, S. Mosesova, L.C. Wu, and O.D. Solberg et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients J Allergy Clin Immunol 130 2012 647 654.e10
84. M. Ultsch, J. Bevers, G. Nakamura, R. Vandlen, R.F. Kelley, and L.C. Wu et al. Structural basis of signaling blockade by anti-IL-13 antibody lebrikizumab J Mol Biol 425 2013 1330 1339
85. A. Tomkinson, J. Tepper, M. Morton, A. Bowden, L. Stevens, and P. Harris et al. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma Allergy 65 2010 69 77
86. A. Tomkinson, C. Duez, G. Cieslewicz, J.C. Pratt, A. Joetham, and M.C. Shanafelt et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness J Immunol 166 2001 5792 5800
87. E. Burmeister Getz, D.M. Fisher, and R. Fuller Human pharmacokinetics/ pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma J Clin Pharmacol 49 2009 1025 1036
88. S. Wenzel, D. Wilbraham, R. Fuller, E.B. Getz, and M. Longphre Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Lancet 370 2007 1422 1431
89. R.E. Slager, G.A. Hawkins, E.J. Ampleford, A. Bowden, L.E. Stevens, and M.T. Morton et al. IL-4 receptor alpha polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist J Allergy Clin Immunol 126 2010 875 878
90. R.E. Slager, B.A. Otulana, G.A. Hawkins, Y.P. Yen, S.P. Peters, and S.E. Wenzel et al. IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor alpha antagonist J Allergy Clin Immunol 130 2012 516 522.e4
91. T. Maes, G.F. Joos, and G.G. Brusselle Targeting interleukin-4 in asthma: lost in translation? Am J Respir Cell Mol Biol 47 2012 261 270
92. T. Kakkar, C. Sung, L. Gibiansky, T. Vu, A. Narayanan, and S.L. Lin et al. Population PK and IgE pharmacodynamic analysis of a fully human monoclonal antibody against IL4 receptor Pharm Res 28 2011 2530 2542
93. J. Corren, W. Busse, E.O. Meltzer, L. Mansfield, G. Bensch, and J. Fahrenholz et al. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma Am J Respir Crit Care Med 181 2010 788 796
94. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, and F. Skobieranda et al. Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 2013 2455 2466
95. L.C. Borish, H.S. Nelson, M.J. Lanz, L. Clauseen, J.B. Whitmore, and J.M. Agosti et al. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial Am J respir Crit Care Med 160 1999 1816 1823
96. L.C. Borish, H.S. Nelson, J. Corren, G. Bensch, W.W. Busse, and J.B. Whitmore et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma J Allergy Clin Immunol 107 2001 963 970
97. B. Mosley, M.P. Beckmann, C.J. March, R.L. Idzerda, S.D. Gimpel, and T. VandenBos et al. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms Cell 59 1989 335 348